ArticleOncology reports2026
[Corrigendum] Compound 225# inhibits the proliferation of human colorectal cancer cells by promoting cell cycle arrest and apoptosis induction.
Article in Oncology reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum for
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Subsequently to the publication of the above paper, the authors have drawn to the attention of the Editorial Office that they made an error in assembling the western blot data in Fig. 3C on p. 6; namely, that the western blot data correctly selected for the P53 protein with the SW620 cell line (right-hand gels) had inadvertently also been included for the γ-H2A.X protein blots with the HCT116 cell line (left-hand gels). Upon analysing this figure further in the Editorial Office, we notified the authors of possibly overlapping α-tubulin control blots for the SW62 cell line in the same figure part, and the authors realized that one of these blots had similarly been chosen incorrectly. The revised version of Fig. 3, now showing the correct γ-H2A.X data for the HCT116 cell line and the correct α-tubulin protein blots for the SW620 cell line, is shown on the next page. The authors wish to emphasize that the corrections made to this figure do not affect the overall conclusions reported in the paper, and they are grateful to the Editor of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.